which patients with dlbcl may benefit from pet-directed induction therapy?
Published 4 years ago • 240 plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
3:59
do the results of the lysa lnh 09-1b trial support a pet-adapted treatment strategy for dlbcl?
-
3:04
pet-directed therapy for early-stage diffuse large b-cell lymphoma
-
3:33
how can diffuse large b-cell lymphoma treatment symptoms be managed?
-
7:50
advice for dlbcl patients
-
5:48
can frontline treatment of dlbcl be improved by combining novel agents with r-chop?
-
3:40
how do we select a patient with r/r dlbcl for car-t?
-
3:53
why is an elderly prognostic index required for patients with dlbcl?
-
2:45
what promising treatments are available for diffuse large b-cell lymphoma patients?
-
1:38
using pet to predict failure to salvage therapy in patients with dlbcl
-
4:16
when will we be seeing changes in the frontline treatment of dlbcl?
-
29:00
dlbcl in 2023: top docs discuss the latest in diffuse large b-cell lymphoma | treatments & research
-
3:50
how can predicting survival in patients with relapsed dlbcl improve treatment decisions?
-
15:50
biomarkers and patient eligibility for car t-cell therapies in dlbcl
-
0:54
pet radiomic features associated with better outcomes after car-t therapy in patients with dlbcl
-
4:47
the polarix trial: initial therapy of diffuse large b-cell lymphoma
-
3:06
results of trial on the use of interim pet scan to identify dlbcl
-
2:44
how can dlbcl patients benefit from shared decision-making?
-
1:16
dr. balzarotti on the challenges of treating elderly dlbcl